Replicor
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
6100 Royalmount Ave, Montreal, Quebec, H...Phone Number
(514) 733-1998Website
www.replicor.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Replicor
Replicor is a clinical-stage biopharmaceutical company focused on developing NUCLEIC ACID POLYMERS (NAPs) for the treatment of chronic hepatitis B (HBV) and hepatitis delta (HDV). Their lead candidate, REP 2139, has demonstrated significant antiviral effects and safety in clinical studies, targeting both viruses through innovative combination therapies. The company aims to provide a cure for HBV and HDV, showcasing unique properties of NAPs that enhance their efficacy while minimizing side effects. Replicor's intended clients include patients suffering from chronic hepatitis infections and healthcare providers seeking advanced treatment options.Explore more
Replicor Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Replicor your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Replicor launches new products
Check if Replicor has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Replicor recently announced quarterly report
Funding: Get notified immidiatlly once Replicor has new funding data
Replicor, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Replicor had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Replicor
Check out if Replicor is spiking on competitors!
Recommended Actions
Find VP level buyers at Replicor
Find more new buyers
Compare Similar Companies to Replicor
Compare insights from companies similar to Replicor, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Replicor is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Replicor is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Replicor.
Replicor Tech Stack
A closer look at the technologies used by Replicor
Replicor News & Media
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Replicor
Sign Up For FreeTo access detailed company insights
Replicor is a clinical-stage biopharmaceutical company focused on developing NUCLEIC ACID POLYMERS (NAPs) for the treatment of chronic hepatitis B (HBV) and hepatitis delta (HDV). Their lead candidate, REP 2139, has demonstrated significant antiviral effects and safety in clinical studies, targeting both viruses through innovative combination thera... Read More
